Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4437959
Max Phase: Preclinical
Molecular Formula: C144H243N41O51
Molecular Weight: 3364.76
Molecule Type: Unknown
Associated Items:
ID: ALA4437959
Max Phase: Preclinical
Molecular Formula: C144H243N41O51
Molecular Weight: 3364.76
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
Standard InChI: InChI=1S/C144H243N41O51/c1-61(2)48-87(172-135(229)105(67(13)14)177-117(211)70(17)159-136(230)108(73(20)189)182-139(233)111(76(23)192)180-130(224)91(52-65(9)10)170-123(217)85(37-42-103(204)205)164-131(225)94(59-186)174-115(209)68(15)145)118(212)154-56-97(195)160-80(30-26-44-152-143(147)148)120(214)167-88(49-62(3)4)126(220)162-82(34-39-100(198)199)119(213)158-69(16)116(210)161-83(35-40-101(200)201)121(215)168-89(50-63(5)6)127(221)171-92(54-79-55-151-60-157-79)128(222)163-84(36-41-102(202)203)122(216)169-90(51-64(7)8)129(223)181-112(77(24)193)140(234)183-110(75(22)191)138(232)173-93(53-66(11)12)141(235)185-47-29-33-96(185)132(226)165-81(31-27-45-153-144(149)150)124(218)179-109(74(21)190)137(231)166-86(38-43-104(206)207)125(219)178-107(72(19)188)134(228)156-57-98(196)175-106(71(18)187)133(227)155-58-99(197)176-113(78(25)194)142(236)184-46-28-32-95(184)114(146)208/h55,60-78,80-96,105-113,186-194H,26-54,56-59,145H2,1-25H3,(H2,146,208)(H,151,157)(H,154,212)(H,155,227)(H,156,228)(H,158,213)(H,159,230)(H,160,195)(H,161,210)(H,162,220)(H,163,222)(H,164,225)(H,165,226)(H,166,231)(H,167,214)(H,168,215)(H,169,216)(H,170,217)(H,171,221)(H,172,229)(H,173,232)(H,174,209)(H,175,196)(H,176,197)(H,177,211)(H,178,219)(H,179,218)(H,180,224)(H,181,223)(H,182,233)(H,183,234)(H,198,199)(H,200,201)(H,202,203)(H,204,205)(H,206,207)(H4,147,148,152)(H4,149,150,153)/t68-,69-,70-,71+,72+,73+,74+,75+,76+,77+,78+,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,105-,106-,107-,108-,109-,110-,111-,112-,113-/m0/s1
Standard InChI Key: QCNPKRHMKSULIF-XAAPULRGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 3364.76 | Molecular Weight (Monoisotopic): 3362.7682 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. (2017) Amylin and calcitonin receptor agonist, |
Source(1):